CPT code 11623 represents the surgical excision of a malignant skin lesion, including margins, for lesions measuring 2.1 to 3.0 cm in diameter on anatomically sensitive sites such as the scalp, neck, hands, feet, or genitalia. This code defines a specific operative service that influences surgical planning, coding accuracy, and national billing patterns for skin cancer treatment.

Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage policies and prior authorization practices among these payers affect site-of-service decisions and documentation requirements for malignant lesion excisions.

Readers will find a concise overview of clinical context and service definition, payer coverage scope, common modifiers associated with the service, and related billing considerations. The publication highlights benchmarks for coding specificity, documentation needed to support lesion size and anatomic site, and common areas of billing denials or audit focus. It also summarizes implications for surgical workflow and claims submission to help clinical and revenue cycle teams align documentation with payer expectations.

Data not available in the input for specific payer rates, regional variations, or ICD-10 mappings; those elements are not included here.